LC

Overview

Founder and Chairman of Aogenics Group, who returned to Taiwan in 2012 to establish a biosimilars-focused CDMO drawing explicit parallels between Taiwan biotech and the TSMC semiconductor trajectory. LC founded Aogenics Group in Taiwan in 2012 after 35 years working in the US biotech and pharma sector, acquiring a biopharmaceutical pilot unit from Taiwan's Ministry of Economic Affairs (MOEA) DCB center. LC drew an explicit parallel between Aogenics's origin from a government-transferred pilot biopharmaceutical unit and TSMC's 1987 spin-off of a government 6-inch semiconductor pilot line, predicting a similar value-creation trajectory for Taiwan biotech. (Segment 5 (20:00-25:00))